Hairong Liu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma (NCT06218004) | Hairong Liu | 2024-01-25 |
Track Hairong Liu automatically
Every clearance here is in the API, with alerts when new ones post.